Litigation

In re Revlimid & Thalomid Purchaser Antitrust Litigation

pending/consolidated

2:19-cv-07532

Court
D.N.J.

Patents at issue (1)

Summary

Consolidated antitrust litigation in D.N.J. in which the '428 patent is cited as part of the challenged Celgene patent portfolio; the court resolved Noerr-Pennington/sham litigation motions in June 2024.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).